Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07321834
PHASE2

A Study to Evaluate AI-09 In Participants With Glabellar Lines

Sponsor: Eirion Therapeutics Inc.

View on ClinicalTrials.gov

Summary

Phase 2 clinical study to evaluate the efficacy, safety, and tolerability of AI-09, a Ready-to-Use Liquid Injectable Botulinum Toxin.

Official title: A Phase 2, Randomized, Double-blind, Vehicle-Controlled, Multi-Center Clinical Trial Study to Evaluate Ready to Use Injectable AI-09 In Participants With Glabellar Lines

Key Details

Gender

All

Age Range

20 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

68

Start Date

2025-12-03

Completion Date

2026-02

Last Updated

2026-01-07

Healthy Volunteers

No

Conditions

Interventions

BIOLOGICAL

AI-09 Ready Use Injectable Botulinum Toxin

AI-09 Ready Use Injectable Botulinum Toxin

BIOLOGICAL

Vehicle

Vehicle

Locations (5)

Center for Clinical and Cosmetic Research

Aventura, Florida, United States

Research Institute of the Southeast, Inc.

West Palm Beach, Florida, United States

Delricht Research

New Orleans, Louisiana, United States

Tennessee Clinical Research Center

Nashville, Tennessee, United States

Research Your Health

Plano, Texas, United States